Monoclonal antibodies used in the treatment of cancer are discussed. Monoclonal
antibodies are a new class of agents targeted at specific receptors on cancer cells. In …

Objective: In women with Human Epidermal growth Receptor 2 (HER2)-positive metastatic
breast cancer (MBC), Trastuzumab has become the standard of care but previous studies …

© 2002 Canadian Medical Association or its licensors convenience—but not price. This
implies that the demand for a medically necessary treatment is independent of price …

Targeted cancer therapies make it possible to tailor cancer treatment. This individualization
of treatment is based on the unique set of molecular targets produced by a patient's tumor …

Objective Since the so-called survival gain is recognised to be a parameter that quantifies
the magnitude of the therapeutic benefit of new treatments, our study is aimed at reviewing …

From Grass Roots to Pharma Partnerships examines the development, over a twenty-year
span, of alliances between grass roots breast cancer groups in Canada and the …

Since their first clinical application in the 1980's recombinant proteins have become an
increasingly larger section of the drug market, growing into a multi-billion dollar global …

Objective Since the so-called survival gain is recognised to be a parameter that quantifies
the magnitude of the therapeutic benefit of new treatments, our study is aimed at reviewing …